Manage Dose Adjustments in Liver Disease

April 2021

You’ll need strategies to adjust med doses in patients with liver impairment...since med labels often lack clear recommendations.

Most meds don’t need dose adjustments until liver function is at least 90% impaired...such as in patients with decompensated cirrhosis who have jaundice or variceal bleeding.

We know liver enzymes (ALT, AST) are just a marker of hepatic injury...not how well the liver is functioning. In fact, these labs may be normal in a patient with advanced cirrhosis.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote